Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06259929
Title NEOadjuvant Abemaciclib and GIredestrant triaL in Patients With ER-positive, HER2-negative Early Breast Cancer (Neo-AGILE)
Acronym Neo-AGILE
Recruitment Not yet recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Fondazione Oncotech
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA

Facility Status City State Zip Country Details
IRCCS Centro di Riferimento Oncologico (CRO) Aviano PN 33081 Italy Details
Humanitas Istituto Clinico Catanese Catania 95045 Italy Details
IRCCS Ospedale Policlinico San Martino Genova 16132 Italy Details
AOU Federico II Napoli 80131 Italy Details
Istituto Nazionale Tumori "G. Pascale" Napoli 80131 Italy Details
Istituto Oncologico Veneto IRCCS Padova 35128 Italy Details
Fondazione Universitaria Policlinico Gemelli IRCCS Roma 00168 Italy Details
Ospedale Fatebenefratelli - Isola Tiberina Roma 00186 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field